Articles in this Section

<< Deal Trackers

Distribution & Marketing
(63 articles)

Editorial >>

<< Previous

Pages 1 ..1 2 3 4 5 6 .. 7

Next >>

Elan Streamlines CNS Portfolio with Divestment of Two Drugs Published: 4 May-2004
By: Business Review Editor
Abstract Fulltext:
Volume: 2004 Issue: 47
Mayne to Market Paxene® in the EU Published: 4 Apr-2004
By: Business Review Editor
Abstract Fulltext:
Volume: 2004 Issue: 46
Shire’s Exit Strategy from Japan Provides Bayer with Exclusive Product Rights Published: 4 Feb-2004
By: Business Review Editor
Abstract Fulltext:
Volume: 2004 Issue: 44
Yamanouchi to Market Aventis’ Peptic Ulcer Drug Amidst Merger Talks Published: 4 Jan-2004
By: Business Review Editor
Abstract Fulltext:
Volume: 2004 Issue: 43
SkyePharma License Marketing and Distribution Rights for DepoCyte® to Mundipharma Published: 1 Aug-2003
By: Business Review Editor
Abstract Fulltext:
Volume: 2003 Issue: 39
OSI Gains US Marketing Rights for Gelclair™ from Celgene Published: 3 Jul-2003
By: Business Review Editor
Abstract
Volume: 2003 Issue: 38
Bayer Buys Marketing Rights to GW Pharmaceuticals’ Cannabis-Based Treatment Published: 3 Jun-2003
By: Business Review Editor
Abstract Fulltext:
Volume: 2003 Issue: 37
Artus Partners with Abbott Laboratories to Market SARS Diagnostic Test Published: 3 Jun-2003
By: Business Review Editor
Abstract Fulltext:
Volume: 2003 Issue: 37
Novo Nordisk and Fournier Pharma Sign Co-Marketing Agreement for Repaglinide in Europe Published: 3 May-2003
By: Business Review Editor
Abstract Fulltext:
Volume: 2003 Issue: 36
Eyetech Pharmaceuticals Enters Deal to Market Pfizer’s Xalatan® Published: 3 May-2003
By: Business Review Editor
Abstract Fulltext:
Volume: 2003 Issue: 36

Bookmarks

Bookmark PharmaDeals through one of these social networks.

Articles in this Section

Login

Bookmarks